{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:51:22Z","timestamp":1774569082597,"version":"3.50.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T00:00:00Z","timestamp":1660694400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Glob. Womens Health"],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Evidence confirmed that the demand for medical abortion (MA) increased significantly during the COVID-19 outbreak in many developing countries including Nigeria. In an abortion-restrictive setting like Nigeria, local pharmacies, and proprietary patent medicine vendors (PPMVs) continue to play a major role in the provision of MA including misoprostol. There is the need to understand these providers' knowledge about the use of misoprostol for abortion and the quality of information they provide to their clients. This analysis is focused on assessing the quality of care provided by both drug seller types, from drug sellers' and women's perspectives.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>This study utilized primary data collected from drug sellers (pharmacists and PPMVs) and women across 6 Local Government Areas in Lagos State, Nigeria. The core sample included 126 drug sellers who had sold abortion-inducing drugs and 386 women who procured abortion-inducing drugs from the drug sellers during the time of the study. We calculate quality-of-care indices for the care women received from drug sellers, drawing on WHO guidelines for medication abortion provision. The index based on information from the sellers had two domains\u2014technical competency and information provided to clients, while the index from the women's perspectives includes an additional domain, client experience.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Results show that the majority of drug sellers in the sample, 56% (<jats:italic>n<\/jats:italic> = 70), were pharmacists. However, far more than half of women 60% (<jats:italic>n<\/jats:italic> = 233) had visited PPMVs. Overall, the total quality score amongst all drug sellers (mean 0.48, SD0.15) was higher than the total score calculated based on women's responses (mean 0.39, SD 0.21). Using our quality-of-care index, pharmacies and PPMVs seem to have similar technical competency (mean score of 0.23, SD 0.13 in both groups (range 0\u20131), whilst PPMV's performed better on the information provided to client domain (mean score of 0.79, SD 0.17 compared with pharmacies 0.69, SD 0.25). Based on women's reports, PPMVs scored better on both quality of care domains (technical competency and information provided to clients) compared with pharmacies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Program\/Policy Implication<\/jats:title><jats:p>In resource-constrained settings such as Nigeria, particularly in the context of health emergencies like COVID-19, there is the need to continue to strengthen and engage PPMVs' capacity and skills in dispensing and administration of MA drugs as a harm reduction strategy. Also, there is the need to target frontline providers in pharmacies for training and skill upscale in MA provision.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgwh.2022.899662","type":"journal-article","created":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T05:24:58Z","timestamp":1660713898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Quality of information offered to women by drug sellers providing medical abortion in Nigeria: Evidence from providers and their clients"],"prefix":"10.3389","volume":"3","author":[{"given":"Akanni","family":"Akinyemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onikepe Oluwadamilola","family":"Owolabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temitope","family":"Erinfolami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Stillman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinrinola","family":"Bankole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/sifp.12049","article-title":"Medical abortion provision by pharmacies and drug sellers in low- and middle-income countries: a systematic review","volume":"49","author":"Footman","year":"2018","journal-title":"Stud Fam Plann."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e0117165","DOI":"10.1371\/journal.pone.0117165","article-title":"A systematic review of the role of proprietary and patent medicine vendors in healthcare provision in Nigeria","volume":"10","author":"Beyeler","year":"2015","journal-title":"PLoS ONE."},{"key":"B3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12913-015-0895-z","article-title":"Care-seeking at patent and proprietary medicine vendors in Nigeria","volume":"15","author":"Prach","year":"2015","journal-title":"BMC Health Serv Res."},{"key":"B4","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1363\/4117015","volume":"41","year":"2015","journal-title":"Int Perspect Sex Reprod Health."},{"key":"B5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4314\/ebomed.v9i2.71688","article-title":"The availability of misoprostol in pharmacies and patent medicine stores in two Nigerian cities","volume":"9","author":"Akiode","year":"2010","journal-title":"Ebonyi Med J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e0209415","DOI":"10.1371\/journal.pone.0209415","article-title":"Trends in misoprostol use and abortion complications: a cross-sectional study from nine referral hospitals in Nigeria","volume":"13","author":"Bello","year":"2019","journal-title":"PLoS ONE"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1363\/2020.32446","volume-title":"From Unsafe to Safe Abortion in Sub-Saharan Africa: Slow but Steady Progress.","author":"Bankole","year":"2020"},{"key":"B8","article-title":"Drug sellers' knowledge and practices, and client perspectives after an intervention to improve the quality of safe abortion care outside of formal clinics in Nigeria","volume-title":"BMJ Sex Reprod Health.","author":"Adojutelegan","year":"2020"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.2105\/AJPH.2016.303446","article-title":"Quality of care in a safe-abortion hotline in indonesia: beyond harm reduction","volume":"106","author":"Gerdts","year":"2016","journal-title":"Am J Public Health."},{"key":"B10","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1080\/07399332.2019.1608207","article-title":"Contextualizing medication abortion in seven African nations: a literature review","volume":"40","author":"Moseson","year":"2019","journal-title":"Health Care Women Int"},{"key":"B11","first-page":"144","article-title":"Women's experiences of self-administration of misoprostol at home as part of early medical abortion","volume-title":"BMJ Sex Reprod Health","author":"Harden","year":"2020"},{"key":"B12","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/01.ogx.0000771048.49678.3d","article-title":"Medical management of induced and incomplete first-trimester abortion by non-physicians in low- and middle-income countries: a systematic review and meta-analysis of randomized controlled trials","volume":"76","author":"Kristiansen","year":"2021","journal-title":"Obstetrical Gynecol Surv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"100057","DOI":"10.1016\/j.conx.2021.100057","article-title":"Medical abortion at 13 or more weeks gestation provided through telemedicine: a retrospective review of services","volume":"3","author":"Kapp","year":"2021","journal-title":"Contracept X."},{"key":"B14","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12913-020-05379-z","article-title":"The potential role of patent and proprietary medicine vendors' associations in improving the quality of services in Nigeria's drug shops","volume":"20","author":"Oyeyemi","year":"2020","journal-title":"BMC Health Serv Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S1473-3099(20)30568-5","article-title":"The indirect impact of COVID-19 on women","volume":"20","author":"Burki","year":"2020","journal-title":"Lancet Infect Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"34670","DOI":"10.1136\/bmjopen-2019-034670","article-title":"Women's self-reported experiences using misoprostol obtained from drug sellers: a prospective cohort study in Lagos State, Nigeria","volume":"10","author":"Stillman","year":"2020","journal-title":"BMJ Open."},{"key":"B17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12884-017-1394-5","article-title":"Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study","volume":"17","author":"Reiss","year":"2017","journal-title":"BMC Pregnancy Childbirth"},{"key":"B18","volume-title":"Medical Management of Abortion","year":"2018"},{"key":"B19","doi-asserted-by":"publisher","first-page":"e003813","DOI":"10.1136\/bmjgh-2020-003813","article-title":"Abortion metrics","volume":"6","author":"Filippi","year":"2021","journal-title":"BMJ Global Health"},{"key":"B20","volume-title":"Medical Management of Abortion","year":"2018"},{"key":"B21","volume-title":"Abortion Care Guideline","year":"2022"},{"key":"B22","unstructured":"2019"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e306","DOI":"10.1371\/journal.pmed.0020306","article-title":"Sources of Contraceptive Commodities for Users in Nigeria","volume":"2","author":"Oye-Adeniran","year":"2005","journal-title":"PLoS Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1093\/heapol\/czh021","article-title":"Interactions between patent medicine vendors and customers in urban and rural Nigeria","volume":"19","author":"Brieger","year":"2004","journal-title":"Health Policy Plan."},{"key":"B25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2190\/IQ.32.3.c","article-title":"A rural\u2014urban comparison of client-provider interactions in patent medicine shops in South West Nigeria","volume":"32","author":"Fajola","year":"","journal-title":"Int Q Commun Health Educ."},{"key":"B26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1136\/jfprhc-2011-100244","article-title":"Family planning providersand#039; perspectives on family planning service delivery in Ibadan and Kaduna, Nigeria: a qualitative study","volume":"39","author":"Hebert","year":"2013","journal-title":"J Family Plann Reprod Health Care."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e54978","DOI":"10.1371\/annotation\/93bc7847-5c4e-4b66-8923-500aa4fa4da5","article-title":"What is the role of informal healthcare providers in developing countries? A systematic review","volume":"8","author":"Sudhinaraset","year":"2013","journal-title":"PLoS One."},{"key":"B28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1093\/intqhc\/mzq022","article-title":"Are interventions for improving the quality of services provided by specialized drug shops effective in sub-Saharan Africa? A systematic review of the literature","volume":"22","author":"Wafula","year":"2010","journal-title":"Int J Qual Health Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e047034","DOI":"10.1136\/bmjopen-2020-047034","article-title":"Sexual and reproductive health services provided by community pharmacists: a scoping review","volume":"11","author":"Navarrete","year":"2021","journal-title":"BMJ Open."},{"key":"B30","volume-title":"WHO on Self-Care Interventions for Health Sexual and Reprod Health and Rights.","year":"2019"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0120637","DOI":"10.1371\/journal.pone.0120637","article-title":"Delivering medical abortion at scale: a study of the retail market for medical abortion in Madhya Pradesh, India","volume":"10","author":"Powell-Jackson","year":"2015","journal-title":"PLoS One."},{"key":"B32","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ijgo.2015.07.008","article-title":"Client\u2013pharmacy worker interactions regarding medical abortion in Zambia in 2009 and 2011","volume":"132","author":"Hendrickson","year":"2016","journal-title":"Int J Gynecol Obstetrics"},{"key":"B33","first-page":"2022","volume":"14","author":"Uzzal","year":"2014","journal-title":"50% Pharmacies Unregistered. DhakaTribune."},{"key":"B34","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/tmi.12062","article-title":"Strengthening pharmacy practice in vietnam: findings of a training intervention study","volume":"18","author":"Minh","year":"2013","journal-title":"Trop Med Int Health."}],"container-title":["Frontiers in Global Women's Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2022.899662\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T05:25:15Z","timestamp":1660713915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgwh.2022.899662\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,17]]},"references-count":34,"alternative-id":["10.3389\/fgwh.2022.899662"],"URL":"https:\/\/doi.org\/10.3389\/fgwh.2022.899662","relation":{},"ISSN":["2673-5059"],"issn-type":[{"value":"2673-5059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,17]]},"article-number":"899662"}}